Sarepta Therapeutics SRPT announced updates from its clinical programs, which focus on targeting different subtypes of limb-girdle muscular dystrophy (LGMD), a group of rare genetic disorders marked ...

A study, published in Nature Communications, sheds light on a newly identified subtype of muscular dystrophy, revealing an unsuspected role of SNUPN gene in muscle cell function. Led by Assistant Prof ...

Dec 3 (Reuters) - Capricor Therapeutics said on Wednesday its cell therapy for a heart condition related ‌to a rare muscular disorder met the ‌main goal of a late-stage study, months after U.S.

When it comes to muscular diseases, most of us have heard of especially common ones like muscular dystrophy and Lou Gehrig's disease. But one of the rarest muscular disorders is also one of the most ...

(Reuters) -BridgeBio Pharma said on Monday its experimental drug for a rare muscle disorder, which currently has no approved treatments, showed improvements in motor and lung function in a late-stage ...

A recent study has found that the SMCHD1 protein plays a key role in controlling how genes are processed, which affects the progression of Facioscapulohumeral Muscular Dystrophy (FSHD). This discovery ...

DeLuca is a freelance journalist covering men’s health, masculinity, and male socialization, with bylines in National Geographic, The Washington Post, Business Insider, and Parents. This is especially ...

Researchers confirm and explore the role of estrogen-related receptors in regulating energy production in muscle cells during exercise. The findings indicate that developing a drug to boost ...

We hypothesize that Duchenne muscular dystrophy and autism spectrum disorder/pervasive developmental disorder co-occur with a greater than random frequency. In this study, we set out to reject the ...

Add Yahoo as a preferred source to see more of our stories on Google. Despite being so rare, "improved awareness and diagnostic techniques have led to more frequent diagnoses and better care," says ...

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) -BridgeBio Pharma said on Monday its experimental drug for a rare muscle disorder, which currently has no approved ...